NCT01826942

Brief Summary

In this study the investigators intend to determine the impact of fractional CO2 laser treatment on the edges of a fresh wound during surgical area closure on thin skin (e.g. face, hands, arms, thorax, etc.) and on thick skin (abdominoplasty procedure) on scar formation. The investigators will also evaluate the effect of shallow fractional laser treatment versus deep parameters settings. If effective treatments could be performed at time of surgery, this would result in both time and cost saving to the patient and to the healthcare system and will improve patient's self-image post surgeries.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2013

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2013

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2013

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

April 4, 2013

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 9, 2013

Completed
Last Updated

March 26, 2014

Status Verified

March 1, 2014

Enrollment Period

2 months

First QC Date

April 4, 2013

Last Update Submit

March 25, 2014

Conditions

Keywords

Scar preventionCO2 fractional laser

Outcome Measures

Primary Outcomes (1)

  • Scar appearance by blinded evaluation of photographs of the three month follow-up visit

    three month follow-up

Study Arms (2)

Thin skin

EXPERIMENTAL

Single fractional CO2 treatment at surgical area closure procedure on thin skin

Device: Lumenis UltraPulse single fractional CO2 laser treatment thin skin

Thick skin

EXPERIMENTAL

Single fractional CO2 treatment at surgical area closure procedure on thick skin

Device: Single fractional CO2 treatment at surgical area closure procedure on thick skin

Interventions

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male or Females
  • At least 18 and no more than 65 years old
  • The surgical area closure in these subjects should be at least 4cm
  • Type of surgery scheduled:
  • Site 1: Surgical area closure on thin skin, including areas that require motion (e.g. face, hands, arms, thorax, etc.) Site 2: Surgical area closure on thick skin (abdominoplasty procedure)
  • Willing to comply with study dosing and complete the entire course of the study

You may not qualify if:

  • Active bacterial, fungal, or viral infection in the treatment area
  • Active cold sores, or herpes in the treatment area
  • Recent excessive exposure to sunlight or artificial UV light (e.g.: use of tanning beds/booths and/or sunbathing) or expectations of tanning during the time of the study
  • History of skin cancer, unless the surgical procedure of issue is for cancer treatment purposes.
  • History of or the presence of any skin condition/disease that might interfere with the diagnosis or evaluation of study parameters (i.e., atopic dermatitis, eczema, psoriasis)
  • Treatment with a systemic retinoid within the past year (e.g., Accutane®, Roche Dermatologics)
  • History or presenting with a keloid scar
  • Any current or recent treatment for cancer, unless the surgical procedure of issue is for cancer treatment purposes.
  • Any uncontrolled systemic disease. A potential subject in whom therapy for a systemic disease is not yet stabilized will not be considered for entry into the study
  • Significant history or current evidence of a medical, psychological or other disorder that, in the investigator's opinion, would preclude enrollment into the study.
  • Subject planning any other cosmetic procedure to the study area during the study period, other than the treatments that will be performed by the investigator
  • Female subject who is pregnant, nursing an infant or is less than 6 months after termination of breast feeding
  • Small surgical closure (\<4cm)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ronald L. Moy, M.D.

Beverly Hills, California, 90210, United States

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 4, 2013

First Posted

April 9, 2013

Study Start

January 1, 2013

Primary Completion

March 1, 2013

Study Completion

March 1, 2013

Last Updated

March 26, 2014

Record last verified: 2014-03

Locations